Retinal Vein Occlusion Market Size, Share & Trend Analysis, Epidemiology and Market Forecast 2030

March 20 15:58 2020
Retinal Vein Occlusion Market Size, Share & Trend Analysis, Epidemiology and Market Forecast 2030

Delveinsight Business Research
DelveInsight’s “Retinal Vein Occlusion Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Retinal Vein Occlusion, historical and forecasted epidemiology as well as the Retinal Vein Occlusion Market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Retinal Vein Occlusion market report provides in-depth current treatment practices, emerging drugs, Retinal Vein Occlusion market share of the individual therapies, current and forecasted Retinal Vein Occlusion market Size from 2017 to 2030 segmented by seven major markets. 

The report also provides comprehensive current Retinal Vein Occlusion Treatment practice & algorithm, market drivers, market barriers and unmet medical needs to cater best of the opportunities and assessments underlying potential of Retinal Vein Occlusion Market.

 

Retinal Vein Occlusion market key facts

  • According to the European Society of Retina Specialists (EURETINA), around 1.1 million people above the age of 55 years are currently affected by an RVO in the European Union with 15–25% due to CRVO, and 75–80% due to BRVO. This corresponds to a prevalence of RVO in either eye of 0.7%.

  • The age and sex standardized prevalence were found to be 5.20 (per 1000) for any RVO, 4.42 for BRVO, and 0.80 for CRVO in the population aged ≥30 years.

  • The United States has the highest percentage of diagnosed and treated patients of Retinal Vein Occlusion.

  • Among the Retinal Vein Occlusion patients, males show a higher proportion of prevalence of RVO as compared to females in the 7MM.

 

Request for Sample Pages: 

https://www.delveinsight.com/sample-request/retinal-vein-occlusion-market

 

Key benefits of Retinal Vein Occlusion Market report

  • Retinal Vein Occlusion market report provides an in-depth analysis of the Retinal Vein Occlusion market, size, share, trend analysis, epidemiology, and market forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.

  • The Retinal Vein Occlusion market report covers Retinal Vein Occlusion current treatment practices, emerging drugs, market share of the individual therapies.

  • The Retinal Vein Occlusion market report covers the marketed and emerging therapies of Retinal Vein Occlusion.

  • The Retinal Vein Occlusion market report helps businesses understand the Retinal Vein Occlusion Market trends that will shape and drive the Retinal Vein Occlusion market in upcoming years.

Retinal Vein Occlusion Market

The Retinal Vein Occlusion market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Retinal Vein Occlusion market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology. 

Retinal Vein Occlusion Market segment gives a thorough detail of Retinal Vein Occlusion Market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight. 

 

Retinal Vein Occlusion Epidemiology

The Retinal Vein Occlusion Epidemiology division provides insights about historical and current Retinal Vein Occlusion patient pool and forecasted trends for every seven major countries. 

The disease epidemiology covered in the report provides historical as well as forecasted Retinal Vein Occlusion Epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030. 

The epidemiology segment also provides the Retinal Vein Occlusion epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan along with diagnosed patient pools and their trends with assumptions undertaken.

 

The launch of the emerging therapies is expected to significantly impact the Retinal Vein Occlusion Treatment scenario in the upcoming years. Some of the emerging therapies in the Retinal Vein Occlusion market include GB-102, ONS-5010, PaniJect, and others. 

Key players in the Retinal Vein Occlusion market include Panoptes pharma, Outlook therapeutics, Graybug vision, Kodiak Sciences, and many others.

 

Table of content

1. Key Insights

2. Executive Summary of Retinal Vein Occlusion

3. Retinal Vein Occlusion Competitive Intelligence Analysis

4. Retinal Vein Occlusion Market Overview at a Glance

5. Retinal Vein Occlusion Disease Background and Overview

6. Retinal Vein Occlusion Patient Journey

7. Retinal Vein Occlusion Epidemiology and Patient Population

8. Retinal Vein Occlusion Treatment Algorithm, Current Treatment, and Medical Practices

9. Retinal Vein Occlusion Unmet Needs

10. Key Endpoints of Retinal Vein Occlusion Treatment

11. Retinal Vein Occlusion Marketed Products

12. Retinal Vein Occlusion Emerging Therapies

13. Retinal Vein Occlusion Seven Major Market Analysis

14. Attribute analysis

15. Retinal Vein Occlusion Market Outlook (in 7 major markets)

16. Access and Reimbursement Overview of Retinal Vein Occlusion

17. KOL Views on the Retinal Vein Occlusion market.

18. Retinal Vein Occlusion Market Drivers

19. Retinal Vein Occlusion Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Related Reports:-

RetinalVeinOcclusion Epidemiology Forecast to 2030

DelveInsight’s ‘Retinal Vein Occlusion Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Retinal Vein Occlusion epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

 

Retinal Vein Occlusion Pipeline Insights, 2020

“Retinal Vein Occlusion Pipeline Insight, 2020” report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the Retinal Vein Occlusion market. A detailed picture of the Retinal Vein Occlusion pipeline landscape is provided, which includes the disease overview and Retinal Vein Occlusion treatment guidelines. 

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

  Categories: